Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Cold salt-water foot baths to prevent paclitaxel-related nerve damage

Official title: The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy

Run by Istanbul Topkapi University · NCT06964802 · Data updated 2026-11-12

This study tests whether taking cold salt-water or plain cold-water foot baths during paclitaxel chemotherapy can prevent or reduce chemotherapy-related peripheral nerve damage in women with breast cancer.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment30 (estimated)
SponsorIstanbul Topkapi University
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Istanbul, Uskudar)
StatusRecruiting
StartedJune 1, 2025
Main results expectedDecember 1, 2025
Study endsJuly 1, 2026
Registry record updatedApril 16, 2026
Trial IDNCT06964802 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 or older with breast cancer who speak Turkish, are scheduled to receive paclitaxel, and have no baseline chemotherapy-associated neuropathy or diabetes are the intended participants.

Probably not a fit

Patients with preexisting peripheral neuropathy, diabetes, foot wounds, peripheral vascular or central nervous system disease, or bone/soft-tissue metastases are unlikely to benefit and are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, controlled trial that assigns Turkish-speaking women with breast cancer receiving paclitaxel to cold salt-water foot baths, unsalted cold-water foot baths, or standard care. Interventions are delivered during chemotherapy and participants are monitored over time using neuropathy screening tools such as the CIPNAT scale, monofilament testing, and vibration testing to track onset, severity, and functional impact. The primary aims are to reduce the incidence and severity of chemotherapy-induced peripheral neuropathy and its effects on daily activities. Key exclusion criteria include preexisting neuropathy, diabetes, foot ulcers, peripheral vascular or nervous system disease, and bone or soft tissue metastases.

Why it matters

Potential benefit: If successful, this low-cost, noninvasive approach could lower how often and how severely paclitaxel causes peripheral neuropathy and help patients keep better daily function.

How similar studies have gone: Related cryotherapy (frozen glove/boot) studies have shown some benefit in small trials, but the use of cold salt-water foot baths for CIPN prevention is relatively novel and not well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women aged 18 and over.
* Conscious
* Speaking and understanding Turkish
* The diagnosis was breast cancer
* Those who will receive paclitaxel chemotherapy
* These are patients who answered 'no' to the 'A' section of the CIPNAT scale

Exclusion Criteria:

* Responding to the vibration test (if the practitioner does not feel the vibration when the patient says they feel the vibration, it means that neuropathy is present)
* Feeling pressure in one or none of the three areas on the plantar surface of the foot according to the monofilament test
* Previous chemotherapy-associated peripheral neuropathy
* Diagnosed with diabetes
* Open wounds or skin ulcers on the foot
* With peripheral and central nervous system disease
* Peripheral vascular disease,
* Patients with bone or soft tissue metastases

Where it's running

  • Haydarpaşa Numune Training and Research Hospital
    Istanbul, Uskudar, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.